11.1 Normal Development & Childhood Immunizations

Normal Development & Childhood Immunizations

Pediatric Growth and Bone Age Interpretation

Pediatric growth monitoring is a cornerstone of well-child checks, reflecting nutritional status, endocrine health, and overall systemic well-being. Normal growth patterns dictate that healthy term infants lose up to 10% of their birth weight in the first few days of life, which should be regained by 10 to 14 days. Subsequently, infants gain approximately 20–30 grams per day during the first three months. As a general rule of thumb, birth weight doubles by 5 months, triples by 1 year, and quadruples by 2 years. Height increases by approximately 50% at 1 year, doubles by 4 years, and triples by 13 years. Head circumference increases by about 2 cm per month for the first three months, then slows, reflecting rapid brain growth.

When evaluating short stature (height < 3rd percentile or a drop across two major percentiles), the clinician must differentiate between normal physiological variants—constitutional delay of growth and puberty (CDGP) and familial short stature—and pathological causes.

• Constitutional delay of growth and puberty is characterized by a delayed bone age (radiographic bone age lagging chronological age by more than two standard deviations). Growth velocity remains normal, and the child's growth curve runs parallel to but below the lower percentiles. Puberty and the pubertal growth spurt are delayed, but ultimate adult height is typically within the mid-parental target range.
• Familial short stature presents with a bone age that is concordant with the child’s chronological age. The child has short parents, a normal growth velocity, and an expected adult height that is short but appropriate for the family.
• Pathological short stature (e.g., growth hormone deficiency, hypothyroidism, Turner syndrome, or celiac disease) is marked by a subnormal growth velocity (< 4–5 cm/year in children aged 2 to puberty) crossing percentiles downward, and often presents with other systemic symptoms, delayed bone age, or specific dysmorphic features.

High-Yield Developmental Milestones

USMLE Step 3 frequently tests the recognition of developmental delays and the differentiation between normal milestones and red flags requiring intervention. Milestones are organized into four domains: gross motor, fine motor, language, and social/cognitive.

• 2 Months: Lifts chest off table when prone (gross motor); tracks objects past midline (fine motor); coos and makes reciprocal vocalizations (language); exhibits a social smile and recognizes primary caregivers (social).
• 4 Months: Rolls from prone to supine (gross motor); reaches for objects and brings hands to midline (fine motor); laughs and squeals (language); looks for sources of sounds (social).
• 6 Months: Rolls supine to prone, sits with minimal support or when propped (gross motor); transfers objects from hand to hand and uses a raking grasp (fine motor); babbles with consonant sounds (language); shows stranger anxiety (social).
• 9 Months: Sits independently without support, pulls to stand, crawls (gross motor); develops an immature pincer grasp using the thumb and side of the index finger (fine motor); understands "no", responds to own name, and babbles specific syllables like "dada/mama" non-specifically (language); plays peek-a-boo and displays separation anxiety (social).
• 12 Months: Walks independently or with support (cruising), stands alone (gross motor); uses a mature pincer grasp (neatly picking up small items between the tips of the thumb and index finger) and throws objects (fine motor); says 1 to 3 specific words (including specific "mama" and "dada") and follows one-step commands with a gesture (language); waves goodbye and points to obtain desired objects (social).
• 18 Months: Runs, walks up stairs with one hand held (gross motor); builds a tower of 3 to 4 blocks, uses a spoon and cup, scribbles (fine motor); has a vocabulary of 10 to 25 words and identifies body parts (language); engages in pretend play and shows ownership ("mine") (social).
• 2 Years: Runs well, kicks a ball, walks up and down stairs one step at a time (gross motor); builds a tower of 6 blocks, copies a vertical line, turns single pages of a book (fine motor); uses 2-word phrases (e.g., "more milk"), has a vocabulary of at least 50 words, and is 50% intelligible to strangers (language); displays parallel play and begins simple toilet training (social).
• 3 Years: Rides a tricycle, climbs stairs alternating feet (gross motor); builds a tower of 9 blocks, copies a circle, uses child safety scissors (fine motor); speaks in 3-word sentences, uses pronouns (I, me, you), and speech is 75% intelligible to strangers (language); participates in group/cooperative play and understands taking turns (social).
• 4 Years: Hops on one foot, throws a ball overhand (gross motor); copies a cross or a square, draws a simple person with 3 parts (fine motor); uses 4-word sentences, knows colors and numbers, and speech is 100% intelligible to strangers (language); exhibits cooperative play and has imaginary friends (social).
• 5 Years: Skips, walks backward, swings (gross motor); copies a triangle, ties shoes, writes some letters/numbers, draws a person with 6 parts (fine motor); speaks in complex sentences and tells stories (language); conforms to rules and shows empathy (social).

Pediatric Screening and Health Surveillance

Well-child checks incorporate standardized screening tools to detect developmental and physical abnormalities early.

1. Developmental and Autism Screening: Standardized developmental screening (e.g., Ages and Stages Questionnaire) is recommended at 9, 18, and 30 months. Specific autism spectrum disorder (ASD) screening utilizing the Modified Checklist for Autism in Toddlers (M-CHAT) is mandated at 18 and 24 months.
2. Anemia and Lead Screening: Universal screening for iron deficiency anemia with a hemoglobin/hematocrit level is performed at 12 months. Risk-based screening is performed earlier if risk factors (e.g., prematurity, early introduction of cow's milk) are present. Lead screening is performed at 12 and 24 months via capillary or venous blood levels in children living in high-prevalence areas or older housing (built before 1978). A venous sample is required to confirm elevated capillary lead levels.
3. Dyslipidemia Screening: Universal screening with a fasting lipid profile or non-HDL cholesterol is recommended once between ages 9 and 11 years, and again between ages 17 and 21 years, to identify familial hypercholesterolemia.
4. Depression and Vision/Hearing: Annual depression screening using the Patient Health Questionnaire-9 (PHQ-9) or PHQ-2 starts at age 12. Visual acuity is screened beginning at age 3 or 4 years using age-appropriate charts, and hearing is screened at birth and annually starting at age 4.

Immunization Schedules, Contraindications, and Catch-Up

Adherence to the Advisory Committee on Immunization Practices (ACIP) schedule is critical for preventing infectious diseases.

• Routine Schedule:

  • Birth: Hepatitis B (HepB).
  • 2, 4, 6 Months: Rotavirus (RV), Diphtheria, Tetanus, and acellular Pertussis (DTaP), Haemophilus influenzae type b (Hib), Pneumococcal conjugate vaccine (PCV15/20), and Inactivated Poliovirus (IPV).
  • 12–15 Months: Measles, Mumps, and Rubella (MMR), Varicella, Hib, PCV, and HepB booster.
  • 12–23 Months: Hepatitis A (2 doses, spaced 6 months apart).
  • 4–6 Years: DTaP, IPV, MMR, Varicella.
  • 11–12 Years: Tdap booster, Meningococcal conjugate (MenACWY), and Human Papillomavirus (HPV, 2 doses if started before age 15).
  • 16 Years: MenACWY booster and Meningococcal B (MenB, shared clinical decision-making).

• Contraindications and Precautions:

  • Live Vaccines (MMR, Varicella, Rotavirus, Intranasal Influenza): Contraindicated in pregnant patients and severely immunocompromised individuals (e.g., congenital immunodeficiencies like SCID, or patients with HIV who have a CD4 count < 200/mm³).
  • Rotavirus Vaccine: Specifically contraindicated in infants with a history of intussusception, severe combined immunodeficiency (SCID), or uncorrected congenital gastrointestinal malformations (such as Meckel's diverticulum).
  • Pertussis-containing Vaccines (DTaP, Tdap): Contraindicated if the patient experienced encephalopathy within 7 days of a previous dose not attributable to another cause. A precaution is an unstable or progressive neurological disorder (e.g., uncontrolled epilepsy), in which case pertussis vaccination should be deferred until the neurological condition is stabilized.
  • Egg Allergy: The CDC recommends that individuals with an egg allergy of any severity can receive any influenza vaccine (egg-based or non-egg-based) that is otherwise age-appropriate, without requiring special medical supervision or prolonged post-vaccination observation beyond routine practice.